[Anti-PLD1 and anti-PD1 in advanced urothelial cancers: promises from early phase trials].

作者信息

Penel Nicolas

机构信息

Centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59000 Lille, France.

出版信息

Bull Cancer. 2016 Oct;103(10):811-812. doi: 10.1016/j.bulcan.2016.08.005. Epub 2016 Oct 4.

DOI:10.1016/j.bulcan.2016.08.005

PMID:27712832

Abstract

摘要

相似文献

[Anti-PLD1 and anti-PD1 in advanced urothelial cancers: promises from early phase trials].

Bull Cancer. 2016 Oct;103(10):811-812. doi: 10.1016/j.bulcan.2016.08.005. Epub 2016 Oct 4.

Treatment of Metastatic Urothelial Cancer in 2018.

JAMA Oncol. 2019 Jun 1;5(6):904-905. doi: 10.1001/jamaoncol.2019.0182.

Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy.

Eur Urol Oncol. 2019 Sep;2(5):565-571. doi: 10.1016/j.euo.2018.09.009. Epub 2018 Nov 8.

Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma.

Int J Clin Oncol. 2011 Oct;16(5):533-8. doi: 10.1007/s10147-011-0224-4. Epub 2011 Mar 23.

Systematic Literature Review and Meta-Analysis of Response to First-Line Therapies for Advanced/Metastatic Urothelial Cancer Patients Who Are Cisplatin Ineligible.

Am J Clin Oncol. 2019 Oct;42(10):802-809. doi: 10.1097/COC.0000000000000585.

Chemotherapy regimen is associated with venous thromboembolism risk in patients with urothelial tract cancer.

BJU Int. 2019 Aug;124(2):290-296. doi: 10.1111/bju.14685. Epub 2019 Feb 19.

Systemic therapy for unresectable and metastatic transitional cell carcinoma of the urothelium: first-line and beyond.

Curr Opin Support Palliat Care. 2008 Sep;2(3):153-60. doi: 10.1097/SPC.0b013e328309c72c.

Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial.

Lancet Oncol. 2017 May;18(5):672-681a. doi: 10.1016/S1470-2045(17)30242-5. Epub 2017 Apr 4.

Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie).

Lung Cancer. 2006 Jan;51(1):105-14. doi: 10.1016/j.lungcan.2005.10.004. Epub 2005 Nov 28.

[First-line treatment of metastatic urothelial carcinoma : Update immuno-oncology].

Urologe A. 2020 Jul;59(7):797-803. doi: 10.1007/s00120-020-01235-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验